EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic nutritional index predicts nintedanib outcomes in idiopathic pulmonary fibrosis

Eri Hayakawa, Motoyasu Kato iD, Haruhiko Hirano, Chisato Tadokoro, Makiko Kohmaru, Takashi Akimoto, Soichiro Soma, Yuta Arai, Shun Nakazawa, Hiroaki Motomura, Takuto Sueyasu, Haruki Hirakawa und 7 weitere

Therapeutic Advances in Respiratory Disease · 2026-08 · 20

DOI: 10.1177/17534666261478394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 12.08.2026. Verfasst von Eri Hayakawa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-Ku, Japan. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Indoles, Nutritional Status, Nutrition Assessment. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malnutrition is common in patients with idiopathic pulmonary fibrosis (IPF), and potentially affects the tolerability of antifibrotic therapy and survival. The prognostic nutritional index (PNI) is a validated prognostic marker in various diseases; however, its role in antifibrotic therapy remains unclear.

Objectives

To investigate associations between the PNI and adverse effects associated with nintedanib, treatment discontinuation, and survival in patients with IPF.

Design

Multicenter retrospective study.

Methods

Data from 167 Japanese patients with IPF who received nintedanib therapy were retrospectively analyzed. Information on clinical characteristics, laboratory data, and adverse events was collected, and the PNI was calculated. The optimal PNI cut-off value was determined using receiver operating characteristic (ROC) curves. Risk factors for treatment discontinuation and survival were identified using Cox proportional hazards models.

Results

The median treatment duration and survival time were 18 and 55 months, respectively. The PNI was significantly higher in patients who experienced nintedanib-associated adverse effects than in those who did not. ROC curve analysis identified an optimal PNI cut-off value of 47.3. Patients with a high PNI had significantly longer treatment durations and survival than those with a low PNI. Multivariate analyses identified the PNI as the only factor independently associated with both time to nintedanib discontinuation and survival.

Conclusion

The PNI predicted treatment feasibility and survival in patients with IPF. These findings highlight the clinical utility of the PNI as a dual biomarker of nutritional status and demonstrate its potential to guide individualized treatment strategies based on nutritional status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisIndolesNutritional StatusNutrition AssessmentProtein Kinase InhibitorsAntifibrotic AgentsHumansFemaleRetrospective StudiesMaleJapanAgedTreatment OutcomeRisk FactorsROC CurvePredictive Value of TestsProportional Hazards ModelsTime FactorsMiddle AgedMultivariate AnalysisAged, 80 and over

Stichwörter der Autor:innen

idiopathic pulmonary fibrosisnintedanibnutritional statusprognostic nutritional indexsurvival analysis

Substanzen

nintedanibIndolesProtein Kinase InhibitorsAntifibrotic Agents

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-Ku, Japan.
  • Department of Respiratory Medicine, Juntendo University Urayasu Hospital, Urayasu, Japan.

ORCID-Profile: Motoyasu Kato

Zitieren

APA

Hayakawa, E., Kato, M., Hirano, H., Tadokoro, C., Kohmaru, M., Akimoto, T., Soma, S., Arai, Y., Nakazawa, S., Motomura, H., Sueyasu, T., Hirakawa, H., Ochi, Y., Sumiyoshi, I., Watanabe, J., Namba, Y., Togo, S., Sasaki, S., & Takahashi, K. (2026). Prognostic nutritional index predicts nintedanib outcomes in idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261478394

Vancouver

Hayakawa E, Kato M, Hirano H, Tadokoro C, Kohmaru M, Akimoto T, et al. Prognostic nutritional index predicts nintedanib outcomes in idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261478394

BibTeX
@article{Hayakawa2026,
  author = {Hayakawa, Eri and Kato, Motoyasu and Hirano, Haruhiko and Tadokoro, Chisato and Kohmaru, Makiko and Akimoto, Takashi and Soma, Soichiro and Arai, Yuta and Nakazawa, Shun and Motomura, Hiroaki and Sueyasu, Takuto and Hirakawa, Haruki and Ochi, Yusuke and Sumiyoshi, Issei and Watanabe, Junko and Namba, Yukiko and Togo, Shinsaku and Sasaki, Shinichi and Takahashi, Kazuhisa},
  title = {Prognostic nutritional index predicts nintedanib outcomes in idiopathic pulmonary fibrosis},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2026},
  volume = {20},
  doi = {10.1177/17534666261478394}
}
Kostenlos starten →